No genetic association detected with mepolizumab efficacy in severe asthma.
Respiratory Medicine(2017)
摘要
•Efficacy pharmacogenetics of mepolizumab treatment in patients with severe asthma was investigated.•A candidate polymorphism analysis and an unbiased genome-wide association analyses were performed.•No genetic effect on mepolizumab treatment response was identified.
更多查看译文
关键词
Severe asthma,Mepolizumab,Pharmacogenetics,Exacerbation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要